Financhill
Back

Sonova Holding AG Quote, Financials, Valuation and Earnings

Sonova Holding AG Price Quote

$73.06
-1.11 (-1.5%)
(Updated: October 31, 2024 at 6:55 PM ET)

Sonova Holding AG Key Stats

Sell
43
Sonova Holding AG (SONVY) is a Sell

Day range:
$74.05 - $75.05
52-week range:
$46.87 - $77.56
Dividend yield:
1.27%
P/E ratio:
33.25
P/S ratio:
5.46
P/B ratio:
8.21%

Volume:
46.2K
Avg. volume:
99.5K
1-year change:
59.75%
Market cap:
$22.5B
Revenue:
$4.1B
EPS:
$2.29

How Much Does Sonova Holding AG Make?

Is Sonova Holding AG Growing As A Company?

Data Unavailable

Sonova Holding AG Stock Price Performance

What Is Sonova Holding AG 52-Week High & Low?

Sonova Holding AG Price To Free Cash Flow

Is It Risky To Buy Sonova Holding AG?

  • How Much Debt Does Sonova Holding AG Have?
    Total long term debt quarterly is $1.7B
  • How Much Cash Does Sonova Holding AG Have?
    Cash and short term investments quarterly total is $569.4M
  • What Is Sonova Holding AG’s Book Value Per Share?
    Book value per share is 9.19

Is Sonova Holding AG Cash Flow Positive?

  • What Is SONVY Cash Flow From Operations?
    Cash flow from operations (TTM) is $858.9M
  • What Is Sonova Holding AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$471.7M
  • What Is Sonova Holding AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$266.3M

Sonova Holding AG Return On Invested Capital

  • Is Management Doing A Good Job?
    SONVY return on invested capital is 18.89%
  • What Is Sonova Holding AG Return On Assets?
    ROA measures how assets are converting to revenues and is 11.17%
  • What Is SONVY Return On Equity?
    ROE is a measure of profitability and is 27.27%

Sonova Holding AG Earnings Date & Stock Price

Sonova Holding AG Competitors

  • Who Are Sonova Holding AG's Competitors?
    Below is a list of companies who compete with Sonova Holding AG or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • Molecular Partners AG (MOLN)
    • NLS Pharmaceutics Ltd (NLSP)

Sonova Holding AG Dividend Yield

Sonova Holding AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many SONVY shares are owned by institutional investors?
    1.8M SONVY shares are owned by institutional investors
  • How many SONVY shares are owned by insiders?
    9.1M SONVY shares are owned by insiders